HRP20140487T1 - Postupak dobivanja perindoprila i njegovih soli - Google Patents

Postupak dobivanja perindoprila i njegovih soli Download PDF

Info

Publication number
HRP20140487T1
HRP20140487T1 HRP20140487TT HRP20140487T HRP20140487T1 HR P20140487 T1 HRP20140487 T1 HR P20140487T1 HR P20140487T T HRP20140487T T HR P20140487TT HR P20140487 T HRP20140487 T HR P20140487T HR P20140487 T1 HRP20140487 T1 HR P20140487T1
Authority
HR
Croatia
Prior art keywords
formula
perindopril
image
salt
acid chloride
Prior art date
Application number
HRP20140487TT
Other languages
English (en)
Inventor
Marjo Merslavic
Janja Smid
Zdenka Tomsic
Original Assignee
Les Laboratoires Servier S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier S.A. filed Critical Les Laboratoires Servier S.A.
Publication of HRP20140487T1 publication Critical patent/HRP20140487T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Claims (6)

1. Postupak dobivanja perindoprila formule I, ili njegovih farmaceutski prihvatljivih soli: [image] , naznačen time što sol kiselinskog klorida formule III [image] reagira s (2S,3aS,7aS)-oktahidroindol-2-karboksilnom kiselinom formule IV [image] , gdje R predstavlja trimetilsililnu skupinu, a R1 predstavlja vodik ili zaštitnu skupinu, poput trimetilsililne skupine, u spoj formule V: [image] , gdje R ima gore navedeno značenje, kojeg se hidrolizom prevodi u perindopril formule I, gdje se reakciju tvorbe peptidne veze provodi u organskim otapalima, poput acetona, acetonitrila, dioksana, kloroforma, metilen-klorida, tetrahidrofurana, ili u njihovoj smjesi s vodom, u prisutnosti baze.
2. Postupak u skladu s patentnim zahtjevom 1 naznačen time što se kiselinski klorid formule III: [image] dobiva prevođenjem N-((S)-1-(etoksikarbonil)butil)-1-alanina formule II: [image] .
3. Postupak u skladu s patentnim zahtjevom 1, naznačen time što se upotrebljava hidrokloridna sol kiselinskog klorida III.
4. Postupak u skladu s bilo kojim od patentnih zahtjeva 1 do 3, naznačen time što se reakcija tvorbe peptidne veze provodi u rasponu temperatura od –20 °C do +20 °C, po mogućnosti na temperaturi od 0 °C do –20 °C.
5. Postupak u skladu s bilo kojim od patentnih zahtjeva 1 do 4, naznačen time što se nakon reakcije hidrolize dobiveni perindopril formule I prevodi u sol perindoprila.
6. Postupak u skladu s patentnim zahtjevom 5, naznačen time što je sol perindoprila sol s t-butilaminom.
HRP20140487TT 2004-05-14 2014-05-29 Postupak dobivanja perindoprila i njegovih soli HRP20140487T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200400143A SI21800A (sl) 2004-05-14 2004-05-14 Nov postopek sinteze perindoprila
SI200400235A SI21852A (sl) 2004-05-14 2004-08-05 Nov postopek sinteze perindoprila
PCT/EP2005/005048 WO2005113500A1 (en) 2004-05-14 2005-05-10 Process for the preparation of perindopril and salts thereof

Publications (1)

Publication Number Publication Date
HRP20140487T1 true HRP20140487T1 (hr) 2014-07-04

Family

ID=34969318

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20140487TT HRP20140487T1 (hr) 2004-05-14 2014-05-29 Postupak dobivanja perindoprila i njegovih soli

Country Status (17)

Country Link
US (1) US7674814B2 (hr)
EP (1) EP1753720B1 (hr)
JP (1) JP5032983B2 (hr)
AU (1) AU2005245087B2 (hr)
CA (1) CA2566754C (hr)
CY (1) CY1115222T1 (hr)
DK (1) DK1753720T3 (hr)
EA (1) EA011322B1 (hr)
ES (1) ES2466248T3 (hr)
HR (1) HRP20140487T1 (hr)
NO (1) NO337892B1 (hr)
PL (1) PL1753720T3 (hr)
PT (1) PT1753720E (hr)
SI (3) SI21800A (hr)
UA (1) UA83139C2 (hr)
WO (1) WO2005113500A1 (hr)
ZA (1) ZA200609915B (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011712B1 (ru) * 2004-03-29 2009-04-28 Ле Лаборатуар Сервье Способ производства твёрдой фармацевтической композиции
US7291745B2 (en) 2005-03-21 2007-11-06 Glenmark Pharmaceuticals Limited Process for the preparation of perindopril
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
JP7070831B2 (ja) 2018-05-31 2022-05-18 株式会社富士通ゼネラル 天井埋込型空気調和機

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
US4508729A (en) 1979-12-07 1985-04-02 Adir Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
IE52663B1 (en) 1980-04-02 1988-01-20 Warner Lambert Co Substituted acyl derivatives of octahydro-1h-indole-2-carboxylic acids
US4425355A (en) 1981-02-17 1984-01-10 Warner-Lambert Company Substituted acyl derivatives of chair form of octahydro-1H-indole-2-carboxylic acids
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
FR2620700B1 (fr) 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620699B1 (fr) 1987-09-17 1990-06-01 Adir Procede de synthese d'alpha amino acides n alkyles et de leurs esters. application a la synthese de carboxyalkyl dipeptides
FR2620703B1 (fr) 1987-09-17 1991-10-04 Adir Procede de synthese industrielle de l'acide perhydroindole carboxylique - 2(2s, 3as, 7as). application a la synthese de carboxyalkyl dipeptides
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
US5258525A (en) 1991-03-27 1993-11-02 Mcneilab, Inc. Processes for preparing [2S-(2α,3aβ,7aβ)]octahydro-1H-indole-2-carboxylic acid and esters
SI9111842A (sl) 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
SI9600169A (en) * 1996-05-22 1997-12-31 Krka Tovarna Zdravil Process for preparation of compounds with ace inhibitory effect
FR2771010B1 (fr) 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2807037B1 (fr) 2000-03-31 2002-05-10 Adir NOUVEAU PROCEDE DE SYNTHESE DES ESTERS DE LA N-[(s)-1- CARBOXYBUTYL]-(S)-ALANINE ET APPLICATION A LA SYNTHESE DU PERINDOPRIL
FR2807431B1 (fr) 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2807430B1 (fr) 2000-04-11 2002-05-17 Adir Nouveau procede de synthese des esters de la n-[(s)-1- carboxybutyl]-(s)-alanine et application a la synthese du perindopril
FR2811319B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
DE10131217A1 (de) 2001-06-28 2003-01-09 Solvay Pharm Gmbh 3-Phenyl-3,7-diazabicyclo 3,3,1 nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AU2002334939A1 (en) 2001-10-12 2003-04-22 Eugene R. Cooper Compositions having a combination of particles for immediate release and for controlled release
DE60312857T2 (de) 2002-01-15 2008-01-17 Actavis Group Hf. Formulierungen von quinapril und verwandte ace-hemmer
EP1333026B1 (en) 2002-01-30 2007-06-27 Les Laboratoires Servier Process for the preparation of high purity perindopril and intermediates useful in the synthesis
AU2003217916A1 (en) 2002-03-08 2003-09-22 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
FR2838648B1 (fr) 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
WO2003103632A1 (en) 2002-06-10 2003-12-18 Elan Pharma International, Ltd. Nanoparticulate polycosanol formulations and novel polycosanol combinations
CA2511004C (en) * 2002-12-23 2015-07-21 Power Measurement Ltd. Power monitoring integrated circuit with communication interface
ES2307923T3 (es) * 2003-02-28 2008-12-01 Les Laboratoires Servier S.A. Procedimiento de preparacion de perindopril y sales del mismo.
DK1338591T3 (da) 2003-02-28 2006-01-23 Servier Lab Fremgangsmåde til syntese af (2S,3aS,7aS)-perhydroindol-2-carboxylsyre og estere heraf samt anvendelse heraf ved syntese af perindopril
ATE281465T1 (de) 2003-03-12 2004-11-15 Servier Lab Verfahren zur synthese von (2s,3as,7as)- perhydroindol-2-carbonsäure und seiner estern, und verwendung in der synthese von perindopril
SI1367061T1 (sl) * 2003-06-30 2006-04-30 Servier Lab Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
US6869963B2 (en) 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
GB2404336A (en) 2003-07-30 2005-02-02 Cipla Ltd Stabilisation of therapeutic agents using a carbonate salt of an amino acid, preferably in the presence of a saccharide, & pharmaceutical compositions thereof
ATE338058T1 (de) * 2003-07-31 2006-09-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
ATE337332T1 (de) * 2003-07-31 2006-09-15 Servier Lab Verfahren für die synthese von perindopril und seiner pharmazeutischen annehmbaren salzen
PT1362845E (pt) 2003-09-01 2009-11-05 Servier Lab Novo processo de síntese dos ésteres da n-((s)-1- carboxibutil)-(s)-alanina e aplicação à síntese do perindopril
EP1403278B1 (fr) 2003-09-30 2005-06-08 Les Laboratoires Servier Procédé de synthèse de la N-((S)-1-carbéthoxybutyl)-(S)-alanine et application à la synthèse du perindopril
EP1400531B1 (fr) 2003-09-30 2006-01-04 Les Laboratoires Servier Procédé de synthèse de la N-[(S)-1-carbéthoxybutyl]-(S)-alanine et application à la synthèse du perindopril
GB2394660A (en) 2003-12-17 2004-05-05 Niche Generics Ltd Stabilisation of pharmaceutical compositions comprising ACE inhibitor by absence of acidic excipients having large specific surface area, eg silicon dioxide
EA011712B1 (ru) 2004-03-29 2009-04-28 Ле Лаборатуар Сервье Способ производства твёрдой фармацевтической композиции

Also Published As

Publication number Publication date
JP2007537189A (ja) 2007-12-20
CA2566754A1 (en) 2005-12-01
SI1753720T1 (sl) 2014-08-29
SI21852A (sl) 2006-02-28
ES2466248T3 (es) 2014-06-09
EP1753720B1 (en) 2014-05-07
WO2005113500A1 (en) 2005-12-01
DK1753720T3 (da) 2014-06-30
NO20065695L (no) 2006-12-11
AU2005245087B2 (en) 2010-12-16
PT1753720E (pt) 2014-08-04
US7674814B2 (en) 2010-03-09
JP5032983B2 (ja) 2012-09-26
CA2566754C (en) 2012-09-18
EA011322B1 (ru) 2009-02-27
AU2005245087A1 (en) 2005-12-01
EA200602117A1 (ru) 2007-04-27
CY1115222T1 (el) 2017-01-04
SI21800A (sl) 2005-12-31
EP1753720A1 (en) 2007-02-21
ZA200609915B (en) 2008-05-28
US20080051584A1 (en) 2008-02-28
NO337892B1 (no) 2016-07-04
UA83139C2 (uk) 2008-06-10
PL1753720T3 (pl) 2014-09-30

Similar Documents

Publication Publication Date Title
HRP20140487T1 (hr) Postupak dobivanja perindoprila i njegovih soli
SU850001A3 (ru) Способ получени производных пролина
KR840005448A (ko) 티에노〔3, 2-c〕 피리딘 유도체의 제조방법
SG187728A1 (en) Processes for preparing tubulysins
DD201782A5 (de) Verfahren zur herstellung von octahydro-1-(omega-mercaptoalkanoyl)-1h-indol 2-carbonsaeure-verbindungen
NZ196704A (en) 1-(omega-mercaptoalkanoyl)-(2alpha,3abeta,7abeta)-octahydro-1h-indol-2-ylcarboxylic acid derivatives
AU602546B2 (en) Pyridazodiazepine derivatives
KR20070110941A (ko) 타달라필 중간체의 제조 방법
PL177549B1 (pl) Pochodne galantaminy oraz kompozycja farmaceutyczna zawierająca pochodne galantaminy
Shin et al. Novel synthesis of the main central 2, 3, 6-trisubstituted pyridine skeleton [Fragment ABC] of a macrobicyclic antibiotic, cyclothiazomycin
SK280831B6 (sk) Spôsob výroby 5,6-dihydro-(s)-4(alkylamino)-(s)-6-alkyl-4h- -tieno[2,3-b]tiopyrán-2-sulfónamid-7,7-dioxidu
NO820903L (no) Fremgangsmaate ved fremstilling av amido-aminosyrer.
Okumura et al. Total Synthesis of a Macrocyclic Antibiotic, Micrococcin P.
JPH01287068A (ja) 4,4―ジ置換プロリンまたは4―モノ置換デヒドロプロリン誘導体
FI84829C (fi) Foerfarande foer framstaellning av cefodizim.
ES2199805T3 (es) Procedimiento para la preparacion de acido (s-(r*s*))-beta-(((1-(1-oxo-3-4-piperidinil)propil)-3-piperidinil)carbonil)amino)-3-piridinoproanoico y derivados.
SI9500140A (en) Novel n-sulfoxy anhydrides, process for the preparation thereof and its use for the preparation of bioactive substances having ace inhibitory action
ES2960492T3 (es) Procedimiento para la preparación de ácido 2-(1-(terc-butoxicarbonil)piperidín-4-il)benzoico
EP1628956B1 (en) A process for the preparation of compounds having an ace inhibitory action
CA1097652A (en) Eprimerization process
Girard et al. Tetrahydro thiadiazolo isoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferase
ES2473271T3 (es) Proceso de preparación de dimiracetam
Shiraiwa et al. Synthesis of optically active homocysteine from methionine and its use in preparing four stereoisomers of cystathionine
IE45811B1 (en) Anthelmintic compounds
CN107129495B (zh) 一种毒扁豆碱前体化合物的制备方法